Amsbio has expanded its range of human blood-derived products including whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells (PBMC).
Blood products from Amsbio are available in a large variety of formats from a broad spectrum of healthy donors, delivered from inventory or collected to order.
Working directly with donors, the company is able to supply self-reported information and other non-invasive samples without relying on clinics.
Samples from donors can be supplied in more than 50 disease indications, including oncology, neurology, immunology, cardio and metabolic diseases.
The team collaborates with major clinical and research centres in Europe, Asia, and the USA to develop collection protocols that are approved by Institutional Review Boards and comply with international and local laws.
Standard patient consent forms and operating procedures are developed to guard patients’ rights and to use all samples with maximum efficiency.
